Member Info for VikR

Research

It is amazing how FAB have managed to acquire Pedro from Fairjourney biologics, a competitor company that was brought out privately in 2024 for 900 million euros. I speculate how this transaction came about as it is very intriguing, according to LinkedIn Pedro was a very involved employee with his former company. Having someone with Pedro’s experience getting the orders in for optimal is such a blessing as he can bring his networking and marketing acumen inherited from his previous role. Fair journey are in a different league to FAB with much higher budgets at the moment but they must be so stressed now with how optimal directly affects their own future pipeline and sales revenue.

No matter how big an organisation it is only as good as how current its tech is, who knows in 5-10’years something will come to better optimal.

I don’t wish bad for anyone but they need to seriously consider collaborating or putting in an offer for FAB outright. Everyone will be able to see the marketing literature and any pharma that can save time and money in future projects will have no reason not to show preference for Optimal. Unfortunately Fairjourney and any other competitors cannot bury their head in the sand any further. Senior level decision makers are in a difficult predicament. I wonder how many more staff may consider the move over to Fusion antibodies, we shall wait and see…..

Yes the former is my buy @ 17.75p not sure what the 17.25p

Just contemplating trimming my ALRT by 5k to bring more here

Decisions, decisions

This is going to go ballistic on the next RNS

Both Kamrun and Jeremy visiting the dignitaries of Cameroon would not have left until they had everything ticked off and good to go. Very very imminent

It’s going to continue going down and your resident ramper PR seems to deem it acceptable to take it out on JAN, we cannot be blamed for the success or failure of MILA. He has resorted to such childish behaviour, please keep him of other boards and let him continue praising MILA here no issue with that, but don’t put JAN in your league, a nil comparable on where we are

Forgot to add in sheer excitement

The Unkown trade for £12375.85 for 70717 shares was a buy, don’t let the MMs fool you and take my buys away.

I am downsizing all my other investments and adding here every step of the way

Adrian has already said we have 1 million pounds worth of leads of organizations looking to use optimal for there next project. Even if only 50% of those genuinelt convert what a start. That’s before they have even officially launched it at San Diego and unleashed Pedro on the sales. To top it all off the scientific community now have the comparables to peruse with the scientific literature shared today. Look at the accuracy of Optimal next to its competitors and who genuinely won’t want to use Optimal for their next project.

Are there any scientists on here who can verify my enthusiasm and claims. I’m not sure everyone realises just how big of a thing this is.

Absolutely why which makes JAN such a compelling but with adding something on top of what we already have. It is very exhilarating to speculate how high the JORC estimate can reach and if it surpasses original hypothesis and projections. This delay of analysis might just be exactly that, it’s so big they need to make sure and double confirm the numbers

Use the contact details to get in touch with the company, perhaps that will prompt them

You consoling me or yourself pal?

We will see as the rest of the week unfolds how low this goes

Yep does make sense

I did load another 1 million shares yesterday at 1.94p. Fully loaded for now and steady increase in the build up to news will do me

I did get back in but seeing the fall I have taken it back out again £28k back out again this morning. As much as I like the back story I have a horrible feeling it is yet to continue dropping and would like to catch the bottom

Who would want to be out here when the fundamentals and technicals are fully aligned and resident chartists have pointed out 21p on the FIB levels as the next target. So far the chart has played pitch perfect and textbook. We have now been given objective data to strengthen our fundamental understanding of optimal. Seeing this board and in general the sentiment is taking care of itself.

I’m glad I had this week off work to track the SP and make sizeable top ups. I hope the rest of the investor community is taking note of this market disruptive tech and awaiting the near term huge re rate.

And on that note a small top up for me 28734 @ 17.34p

Still hugely undervalued

Chart looks like it’s bursting to break this range and target the upside. Loaded up heavy yesterday @ £25k so hope this has long legs to run unilaterally upwards

This literature is being compared to the same competitors where Pedro our new BDM was also an employee?

Which means he has all the industry contacts already and can tell his potential buyers just how good optimal is. What a tactical genius move and no wonder he is also on the trip to San Diego considering he has just joined the business this month

This still remains one of the best evidenced based strategic buys of 2025

With news extremely close it makes nil sense to be out of this share at such a crucial inflection point

Load and hold

I have had most success from those investments where the market cap is at a disconnect to the assets in situ. The SP as a numerical figure in time is essentially irrelevant.

This is why I have loaded heavy here and at JAN with this strategy in mind, which in historical experience has proven to be financially rewarding

Good luck ALTHs and any new investors considering joining after doing your due diligence

There is a reason why Dr Mitch Ho is so fond of fusion antibodies and his passion for the continued use of optimal. He is head speaker and organiser at the conference next week in San Diego and what better independent validation then the chief organiser of the event giving his first hand experience of using optimal for some time now.

We have now quantified the science and the literature is out and ready to be publicized for San Diego where the influential potential end users who need to see it can take it away and compare for themselves.

Optimal is not just another step up or add on, to re iterate for our non scientific investors IT IS A ONE

IN A LIFETIME INVENTION, that may not get replicated ever again.

Proud of Northern Ireland and the BOD in making this happen. They deserve accolades and awards for this which will land in due course

I did encourage them to get some tangible updates on there X account and glad they have taken it on board. Great consistent results as I had expected

Why this is still sitting below 3p is absurd. This should be 5p+ now all day long. Fortunately topped up beginning of this week

Glad to have topped up here again yesterday

Director buys

Increased stake pre report

Report landing in one week

There could not be any more bullish signs as to positive content of the report

Load and hold astute investors

Took a holding for 5k 11480574 shares @ 0.43p

Let’s see what happens - speculative for me